Literature DB >> 1827918

Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.

M Krych1, D Hourcade, J P Atkinson.   

Abstract

Cysteine-rich repeated units of 40-70 amino acids are building blocks of many mammalian proteins, including 12 proteins of the complement system. Human complement arranged motifs, designated short consensus repeats (SCRs), which constitute the entire extracellular portion of this protein. Klickstein et al. [Klickstein, L. B., Bartow, T. J., Miletic, V., Rabson, L. D., Smith, J. A. & Fearon, D. T. (1988) J. Exp. Med. 168, 1699-1717 (abstr.)] localized a C4b binding domain to SCR-1 and/or SCR-2 and a C3b binding domain to SCR-8 and/or SCR-9. These SCRs bind different ligands, although SCR-1 and SCR-8 are 55% homologous and SCR-2 and SCR-9 are 70% homologous. To examine if one or two SCRs are required for ligand binding and to define sites within the SCRs that determine specificity of binding, mutagenesis analysis of a truncated, secreted form of CR1, called CR1-4 by Hourcade et al. [Hourcade, D., Meisner, D. R., Atkinson, J. P. & Holers, V. M. (1988) J. Exp. Med. 168, 1255-1270], was undertaken. The latter, composed of the first eight and one-half amino-terminal SCRs of CR1, efficiently bound C4b but not iC3. SCR-1 and SCR-2 were necessary for this interaction. Analysis of the mutant CR1-4 proteins, in which amino acids in SCR-1 and SCR-2 were substituted a few at a time with the homologous amino acids of SCR-8 and SCR-9, led to the identification of one amino acid in SCR-1 and three amino acids in SCR-2 important for C4b binding. Furthermore, five amino acids at the end of SCR-9, if placed in the homologous positions of SCR-2, conferred iC3 binding and are likely essential for ligand binding activity of SCR-8 and SCR-9. This iC3 binding occurred only if SCR-1 was present, indicating that two contiguous SCRs are necessary for this interaction. These results provide identification of amino acids within SCRs that are important for ligand binding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827918      PMCID: PMC51657          DOI: 10.1073/pnas.88.10.4353

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Structure-function relationships of the complement components.

Authors:  K B Reid; A J Day
Journal:  Immunol Today       Date:  1989-06

3.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

4.  Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.

Authors:  M A Arnaout; N Dana; J Melamed; R Medicus; H R Colten
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

5.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

6.  Polymorphism of human erythrocyte C3b/C4b receptor.

Authors:  T R Dykman; J L Cole; K Iida; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

Authors:  C A Lowell; L B Klickstein; R H Carter; J A Mitchell; D T Fearon; J M Ahearn
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.

Authors:  T A McNearney; C Odell; V M Holers; P G Spear; J P Atkinson
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.

Authors:  L B Klickstein; T J Bartow; V Miletic; L D Rabson; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  36 in total

1.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

Review 2.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

Review 3.  How novel structures inform understanding of complement function.

Authors:  Elena Goicoechea de Jorge; Hugo Yebenes; Marina Serna; Agustín Tortajada; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  Semin Immunopathol       Date:  2017-08-14       Impact factor: 9.623

4.  Mapping epitopes for 20 monoclonal antibodies to CR1.

Authors:  M Nickells; R Hauhart; M Krych; V B Subramanian; K Geoghegan-Barek; H C Marsh; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.

Authors:  Jie Li; Jennifer P Wang; Ionita Ghiran; Anna Cerny; Alexander J Szalai; David E Briles; Robert W Finberg
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

6.  Identification of a complement receptor 1 peptide for inhibition of immune hemolysis.

Authors:  Jin Yu; Susanne Heck; Asim Debnath; Karina Yazdanbakhsh
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

7.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

8.  Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Authors:  Hyon Ju Park; Mara Guariento; Mateusz Maciejewski; Richard Hauhart; Wai-Hong Tham; Alan F Cowman; Christoph Q Schmidt; Haydyn D T Mertens; M Kathryn Liszewski; Dennis E Hourcade; Paul N Barlow; John P Atkinson
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

9.  A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

Authors:  D V Tambourgi; T L Kipnis; W D da Silva; K A Joiner; A Sher; S Heath; B F Hall; G B Ogden
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1.

Authors:  Ionita Ghiran; Aleksandra M Glodek; Gregory Weaver; Lloyd B Klickstein; Anne Nicholson-Weller
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.